Elanco Animal Health Incorporated Shareholders' Equity
Elanco Animal Health Incorporated (ELAN) had Shareholders' Equity of $6.59 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.59B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.50B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.55B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.75B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $6.59B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $6.50B 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $6.55B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $6.75B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $6.78B 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $6.35B 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $6.10B 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $6.52B 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $5.94B 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $6.06B 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $6.22B 10-K · filed 2026-02-24 | |
| 2023-09-30 | $6.13B 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $7.42B 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $7.48B 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $7.29B 10-K · filed 2026-02-24 | |
| 2022-09-30 | $6.71B 10-Q · filed 2023-11-07 | $6.75B 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.13B 10-Q · filed 2023-11-07 | $7.14B 10-Q · filed 2022-08-08 |
| 2022-03-31 | $7.58B 10-Q · filed 2023-11-07 | $7.61B 10-Q · filed 2022-05-09 |
| 2021-12-31 | $7.51B 10-K · filed 2025-02-25 | $7.54B 10-K · filed 2022-02-28 |
| 2021-09-30 | $7.68B 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $7.98B 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $8.01B 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $8.46B 10-K · filed 2024-02-26 | $8.48B 10-K · filed 2021-03-01 |
| 2020-09-30 | $8.34B 10-Q · filed 2021-11-05 | $8.34B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $6.65B 10-Q · filed 2021-11-05 | $6.65B 10-Q · filed 2020-07-30 |
| 2020-03-31 | $6.66B 10-Q · filed 2021-11-05 | $6.66B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.54B 10-K · filed 2023-03-01 | $5.55B 10-K · filed 2020-02-28 |
| 2019-09-30 | $5.49B 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $5.27B 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $5.20B 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $5.20B 10-K · filed 2022-02-28 | $5.20B 10-K · filed 2019-02-20 |
| 2018-09-30 | $5.14B 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $7.58B 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $7.90B 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $7.78B 10-K · filed 2021-03-01 | |
| 2017-09-30 | $7.96B 10-Q · filed 2018-11-08 | |
| 2016-12-31 | $7.02B 10-K · filed 2020-02-28 | |
| 2015-12-31 | $7.43B 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |